A novel investigational PET imaging agent can rapidly and accurately visualize lesions in clear cell renal cell cancer (ccRCC) patients according to new research published in the May issue of The Journal of Nuclear Medicine.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19 infection has led to worsened outcomes for patients with cancer. SARS-CoV-2 spike protein mediates host cell infection and cell-cell fusion that causes stabilization…
Get latest articles and stories on India at LatestLY. The Delhi High Court has imposed costs of Rs 50,000 on New India Assurance Company Ltd for the "harassment and mental agony" caused to a cancer patient, who was deprived of the claim…
An expanding pipeline of vaccines is giving patients new hope against some of the deadliest cancers, by training the body's immune system to attack malignancies.
Anne Shaw, 68, was given the devastating diagnosis after doctors repeatedly failed to spot a golf-ball sized ovarian tumour clearly visible in a 2019 scan.
Researchers at Bar-Ilan University have unveiled a technology that promises to improve cancer treatment decisions based on a patient's biopsy. The pioneering biological research and development measures changes in immune system cells…
Currently patients with a form of the disease which has spread to one or two other parts of the body are assumed to be resistant to milder hormone therapy drugs
Patient-generated "passive data," collected from smartphones, offers an alternative – continuous, real-time insights into the health and behavior of those living with ...
Johnson & Johnson's results in treating bladder and prostate cancer. Learn about TAR-210's efficacy in high-risk NMIBC patients and TAR-200's promising outcomes for BCG-unresponsive cases.
Researchers at the University of Kentucky College of Nursing and DanceBlue Kentucky Children's Hospital Hematology/Oncology Clinic found that receiving financial and legal navigation services improves levels of financial toxicity and…
In an editorial, published in Oncoscience, researcher Rafael Parra-Medina from Fundación Universitaria de Ciencias de la Salud and Instituto Nacional de Cancerología discusses Latin America's (LA) population—a heterogeneous mix of…
Glioblastoma is an often fatal form of brain cancer, with only 5% of patients surviving beyond five years. The cancer is difficult to treat and almost always becomes resistant to treatment. As a result, recurrence of glioblastoma is…
Paul Carroll said he came back from Canada ‘with assurances’ from hospital management but now has no alternative but to move to Sligo for family reasons
The pioneering biological research and development measures changes in immune system cells adjacent to cancer cells, providing crucial insights into the patient's immune response and potentially enhancing the effectiveness of immunotherapy.
(MedPage Today) -- SAN ANTONIO -- Extended compared with standard lymphadenectomy at the time of radical cystectomy provided no survival benefit to patients with muscle-invasive bladder cancer (MIBC), according to a phase III trial.
Watchdogs last week gave the green light for pembrolizumab after studies suggested patients with Hodgkin's lymphoma on it lived longer than those given radiotherapy and chemotherapy.